Phagocytosis is an essential innate immunity process for the recognition, engulfment and clearance of foreign particles that is driven by actin polymerization 1 . Phagocytosis is activated by the engagement of ligands with phagocytic receptors, through the ligation of IgGopsonized particles with the Fc receptor (FcγR) or C3bi-opsonized particles with the complement receptor 3 (CR3) 2 . These interactions give rise to the recruitment and/or activation of components that orchestrate actin polymerization beneath the phagocyte membrane to reshape the membrane in order to cover the particle 1 . The actin cytoskeleton contributes force and scaffolding for the formation and closure of the phagocytic cup. The process is orchestrated by a variety of actin-regulating proteins that are recruited to the phagocytic cup at different phases of the membrane-remodeling process. Disruption of protein expression or function leading to impairment of phagocytosis in macrophages has been used to demonstrate the importance of many actin-regulating proteins in this process, including CapG 3 , gelsolin 4 , diaphanous 5 , WASP 6 , WIP 7 and VASP 8 .
a r t i c l e s
Phagocytosis is an essential innate immunity process for the recognition, engulfment and clearance of foreign particles that is driven by actin polymerization 1 . Phagocytosis is activated by the engagement of ligands with phagocytic receptors, through the ligation of IgGopsonized particles with the Fc receptor (FcγR) or C3bi-opsonized particles with the complement receptor 3 (CR3) 2 . These interactions give rise to the recruitment and/or activation of components that orchestrate actin polymerization beneath the phagocyte membrane to reshape the membrane in order to cover the particle 1 . The actin cytoskeleton contributes force and scaffolding for the formation and closure of the phagocytic cup. The process is orchestrated by a variety of actin-regulating proteins that are recruited to the phagocytic cup at different phases of the membrane-remodeling process. Disruption of protein expression or function leading to impairment of phagocytosis in macrophages has been used to demonstrate the importance of many actin-regulating proteins in this process, including CapG 3 , gelsolin 4 , diaphanous 5 , WASP 6 , WIP 7 and VASP 8 .
Because actin polymerization is vital to phagocytosis, interfering with actin dynamics is a frequent strategy for pathogen survival within host species. Thwarting macrophage phagocytosis prevents the clearance of bacteria during infection, thus leading to their propagation within the host. Pathogenic Yersinia species use type III secretion systems (T3SSs) to inject effector proteins into the cytosol of phagocytic cells, thus interfering with a variety of immune-cell functions to evade host immune systems 9 . One of these pathogenic Yersinia species, Yersinia pestis, is the causative agent of the bubonic plague, which is estimated to have claimed more than a hundred million lives in numerous pandemics through the course of civilization, including the Plague of Justinian (541-542) 10 , the Black Death (1347-1351) 11 and the Third Pandemic 12 . Y. pestis is highly infectious and lethal if left untreated, and in the 21st century it continues to claim lives 13 . Although infections can now be successfully treated with antibiotics, the discovery of strains that have acquired self-transmissible plasmids conferring antibiotic resistance has fueled concerns of the reemergence of Y. pestis epidemics 14 .
YopO, also known as YpkA, one of the effectors injected by the T3SS, contributes to the disabling of phagocytosis by disruption of the actin cytoskeleton. The phosphorylation activity of YopO is specifically required for the inhibition of Yersinia YadA-dependent phagocytosis 15 . YopO has three functional regions: an N-terminal region that targets it to the inner surface of the host-cell plasma membrane (residues 1-88) 16, 17 ; a region homologous to eukaryotic serine/threonine kinases (residues 115-431) 18, 19 ; and a Rho GTPase-binding domain (residues 434-729) that serves as a guanine-nucleotide dissociation inhibitor (GDI) 20 . YopO sequesters RhoA and Rac, turning off their activation of the actin-polymerization machineries (although it does not sequester Cdc42) 21 . The structure of YopO's GDI domain was previously elucidated in isolation and in complex with Rac1. In both structures, the GDI region is an elongated helical domain composed of two distinct subdomains held together by a 65-Å-long 'backbone' helix 20 . Both the kinase and the GDI domains interact with actin, and binding to host actin is essential to YopO's kinase activity 15, 19 . Cytoplasmic actin stimulates autophosphorylation of YopO more effectively than muscle actin isoforms 15 . Overexpression of YopO in HeLa cells induced actin-filament disruption and cell retraction from the substratum 17, 19, 21 , whereas overexpression of the kinase-dead mutant resulted in an intermediate phenotype 19, 20 , thus suggesting that YopO affects the actin cytoskeleton through both kinase-dependent and kinase-independent mechanisms 22 . YopO has been found to inhibit Gα q signaling pathways through its kinase activity 23 .
At present, little is known about the kinase function of YopO or of its kinase substrates.
Here we set out to identify the molecular mechanisms of the kinase domain of YopO. We report the crystal structure of YopO encompassing the kinase and GDI domains in complex with its activator, actin. The structure, together with biochemical data, reveals the GDI-independent mechanisms of YopO. YopO binds to the pointed face of an actin monomer, sterically blocking actin polymerization while using the bound actin as bait to recruit regulators of actin polymerization, thus leading to their phosphorylation and potential misregulation. We then demonstrated that YopO-induced phosphorylation of VASP impairs its ability to accelerate the polymerization of profilin-actin in vitro.
RESULTS

Structure determination of the YopO-actin complex
We determined the crystal structure of Yersinia enterocolitica YopO encompassing the kinase and GDI domains, bound to actin. Y. enterocolitica causes the zoonotic disease yersiniosis, which affects humans, and its YopO shares 97% sequence identity with that from Y. pestis (Supplementary Fig. 1 ). Initial crystallization efforts failed to produce crystals suitable for high-resolution structural studies. Surface entropy reduction 24 yielded crystals that diffracted X-rays to 2.65 Å, thus leading to our determination of the structure ( Table 1 and Supplementary Fig. 2 ). The structure revealed that YopO interacts with actin at an unusual site, sandwiching actin subdomain 4 between the GDI and the kinase domains of YopO (Fig. 1a) . The catalytic cleft of the kinase domain, being flanked between the kinase domain and the GDI domain, which lie ~33 Å apart, potentially restricts the dimensions of the phosphorylation targets that can be inserted into this groove. The YopO-actin complex has an extensive interaction interface of 2,034 Å 2 , with the kinase domain (1,220 Å 2 ) occluding a larger surface area on actin than the GDI domain (814 Å 2 ). In the YopO-actin complex, actin adopts a native actin-ATP monomer conformation with a typically disordered DNase I-binding loop (residues [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] 25 . The interaction of YopO with actin leaves the profilinbinding site on actin unobscured, thus confirming previous studies reporting copurification of profilin with YopO and actin 19 .
Conformational changes to the GDI domain upon actin binding
The actin-bound GDI domain maintains its structure as an elongated helical-rich domain, composed of two distinct subdomains held together by the backbone helix, except that the backbone helix (α14) bends by 30°, to result in the translocation of the GDI N-terminal subdomain (helices α14-18) by 30 Å toward actin (as measured for Thr655 on α16 helix) (Fig. 1b) 17, 20 . In all three GDI structures (actin bound, Rac1 bound and unbound), the conformation of the Rac1-binding interface of YopO appears to be equally accessible (Supplementary Fig. 2b) , and residues 513-532, which connect helices α11 and α12 are disordered (Supplementary Fig. 1 ). The binding sites on YopO for Rac1 and actin are well separated from each other and from the active site of the kinase domain. This, together with the conservation of the conformation of the Rac1-binding interface, suggests that simultaneous interactions at these three sites may occur (Fig. 1b) . The interaction of the GDI domain with actin is mediated by the loop between helix α15 and α16 and three (α16-18) of the four helices within the GDI C-terminal subdomain. This is consistent with data indicating that the C-terminal 20 residues of YopO are important for binding to actin (refs. 15,19 and Fig. 1) .
Interaction of the kinase domain of YopO with actin
The kinase domain adopts the canonical bilobed kinase fold with an N lobe (residues 108-214) and a larger C lobe (residues 215-425) (Fig. 1d) . The kinase domain is in an active conformation, with a well-defined activation segment (residues 286-308). The first 19 residues (89-107) are disordered and encompass the phosphorylation sites Ser90 and Ser95 (ref. 15 ; sequence alignment in Supplementary  Fig. 1 ). There is no evidence in the electron density map of phosphorylation on the activation segment or elsewhere in the ordered structure. The kinase domain interacts with actin via the back of the C lobe, through the linker between helices α2 and α3 and a long connecting polypeptide chain between helices α4 and α5 ( Fig. 1d and Supplementary Note). The latter appears to be a unique feature among serine/threonine kinases and is an adaptation for interaction with actin ( Supplementary Fig. 2c ). The interaction between actin and the kinase domain appears to contribute to the activation of the kinase domain by the allosteric positioning and stabilization of the activation segment and the catalytic loop, thus providing the structural explanation for actin-induced kinase activation.
Mechanism of actin-monomer sequestration
YopO clamps around actin subdomain 4 (Fig. 1a) , blocking the pointed face of the actin monomer. Superposition of the structure of YopO bound to an actin monomer onto the structure of the actin filament 26 revealed that the bound monomer is incapable of incorporation into the filament, owing to steric hindrance conferred by YopO, thus precluding the YopO-actin complex from joining the barbed end of a filament (Fig. 2a) . This provides a structural basis for the inhibition of actin polymerization by YopO that is seen in pyrene-actin assays 15 , with nearly complete inhibition at an equimolar ratio of YopO to actin (Fig. 2b) . YopO nRac, with mutations made to the Rac-interaction interface of YopO (YopO nRac: Y588A N592A E596A) 20 , like YopO wild type (WT), abolishes actin a r t i c l e s npg a r t i c l e s polymerization when at equimolar ratio to actin and is autophosphorylated in the presence of actin (Fig. 2c) . Mutations introduced to the actin-binding interface of YopO on the basis of the structure (YopO nAct: V374D T376D R723A E727A) greatly reduce YopO's ability to prevent actin polymerization and to autophosphorylate ( Fig. 3b ). Unlike Tmod3, which serves as a positive control and inhibits depolymerization through pointed-end capping, YopO does not slow depolymerization and thus does not cap the pointed ends of actin filaments (Fig. 2d) .
Basis for actin-isoform preference
Rabbit skeletal α-actin is relatively weaker in activating the autophosphorylation of YopO as compared to Dictyostelium discoideum or platelet (a mixture of β and γ isoforms) cytoplasmic actins 15 . The YopO-actin structure clarifies the differential activation of YopO by cytoplasmic versus muscle actin isoforms. Sequence alignment of homologous actinscytoplasmic isoforms (human β-actin, mouse a r t i c l e s β-actin, Spodoptera frugiperda (Sf9) actin and D. discoideum actin) and a muscle isoform (rabbit skeletal α-actin)-yielded a number of candidate residues that are conserved among cytoplasmic isoforms but are different in the muscle isoform ( Supplementary Fig. 4) . One of these residues is involved in a direct interaction with YopO. Thr202 is conserved in S. frugiperda and D. discoideum actins and in the corresponding positions in human β-actin (Thr201) and mouse β-actin (Thr201). In the YopO-actin structure, actin Thr202 forms a hydrogen bond with Lys245 of YopO with a bond length of 2.9 Å (Fig. 3a) . The corresponding residue is Val203 in rabbit α-actin, which is unable to form a side chain hydrogen bond with lysine (Fig. 3b) .
To test the hypothesis that the ability to form a hydrogen bond between Lys245 of YopO and Thr202 of actin contributes to the differentiation between muscle and nonmuscle actin isoforms, we designed a mutant, YopO K245M, to abolish this hydrogen bond. We tested YopO WT and K245M for the ability to sequester actin in a polymerization assay and found that the sequestration activity of the K245M mutant toward human cytoplasmic actin and Sf9 actin is attenuated in the polymerization assay compared to that of YopO WT (Fig. 3c) . In contrast, YopO WT and K245M sequester rabbit α-actin to a similar extent. This confirms that the hydrogen bond between Lys245 of YopO and Thr202 of actin confers upon YopO the ability to distinguish between muscle and cytoplasmic actin isoforms and provides a structural basis for the differential autophosphorylation of YopO in the presence of muscle and cytoplasmic actin isoforms 15 .
YopO-bound actin interacts with other actin-binding proteins
The majority of actin-regulating proteins bind to actin between subdomains 1 and 3 (refs. 27,28) , whereas the binding of YopO to actin leaves this region unobstructed. This prompted an investigation via quantitative proteomics into the interaction of YopO with actin and other actin-binding proteins. We used histidine-tagged YopO to affinity purify endogenous actin and interacting partners from macrophage Raw264.7 cell lysate via stable-isotope labeling of amino acids in cell culture (SILAC) followed by MS analysis 29 . Proteins that were enriched above a cutoff normalized heavy/light (H/L) ratio of 4 include actin and Rac2 as well as many actin-binding proteins including profilin; the filament elongators EVL and VASP; the formins diaphanous 1 (mDia1) and INF2; the Arp2/3-complex activator WASP and the WASP-binding protein WIP; the severing protein gelsolin; and the depolymerizing protein cofilin1 ( Table 2) . Superposition of the structures of actin in complex with profilin and the G-actin-binding domain of VASP (structure from ref. 30) (Fig. 4a) , gelsolin domains 1-3 (structure from ref. 31) (Fig. 4b) (Fig. 4c) , with the YopO-actin complex revealed no steric clashes. This supports the notion that these actin-binding proteins may form ternary complexes with YopO through binding directly to actin. We tested the formation of ternary complexes with YopO-actin for a subset of proteins identified in Table 2 . A number of them were stable enough to be reproduced on size-exclusion chromatography with purified proteins, including profilin, gelsolin domain 1, cofilin and CapG (Fig. 4d-g ).
YopO nRac behaves like YopO WT in sequestering G-actin in the pyrene-actin polymerization assay and in autophosphorylation in the in vitro phosphorylation assay (Fig. 2b,c) , thus suggesting that Rac sequestration is independent of actin binding and kinase activation. Affinity purification with histidine-tagged YopO nRac against the Table 2) . Indeed, all of the common high-confidence interaction partners between the MS data sets in Table 2 were either actin or actin-binding proteins. As such, actin binding and recruitment of actin-binding proteins by YopO occurs independently of Rac sequestration.
YopO uses actin as bait for phosphorylation
The ability of YopO to be activated by actin and to recruit a multitude of actin-binding proteins, coupled with the positioning of the catalytic cleft of the kinase domain proximal to actin, suggests that YopO may use actin as bait for the recruitment of kinase substrates. We tested a subset of proteins identified to form ternary complexes with YopO-actin ( Table 2 ) to identify substrates for phosphorylation by YopO. We incubated purified proteins, or protein fragments, with YopO and insect cytoplasmic Sf9 actin in the presence of [γ-32 P]ATP in in vitro phosphorylation assays. VASP, EVL, mDia1, WASP and gelsolin were phosphorylated, whereas CapG and Twf1 remained unmodified (Fig. 5a) . To test the hypothesis that YopO uses actin as bait for the recruitment of substrates, we added a three-fold molar excess of gelsolin domain 1 (G1) to the phosphorylation assay to compete for binding to actin and, in a parallel experiment, added a three-fold molar excess of profilin. G1 binds to actin between subdomains 1 and 3 (K d = 5 pM) 34 and forms a ternary complex with YopO-actin (Fig. 4b,e) . It acts as a competitor for the common binding site of VASP (Fig. 4a) , EVL, WASP (Fig. 4c) , gelsolin and mDia1 on actin, which lies between subdomains 1 and 3 (refs. 27,28) . In agreement with the bait hypothesis, the phosphorylation of VASP, EVL, WASP, gelsolin and mDia1 was substantially reduced in the presence of competition from excess G1. The presence of G1 does not disrupt the YopO-actin interaction, because the autophosphorylation of YopO remained robust (Fig. 5a) . As a comparison, we used profilin in place of G1, because profilin-actin comprises the major part of the polymerization-competent G-actin pool within cells 28 . Profilin also binds actin between subdomains 1 and 3 (K d = 0.7 µM) 35 in a tricomplex with YopO (Fig. 4a,d ) but is compatible with binding to VASP, EVL, mDia1 and WASP, because these proteins contain polyproline regions that can interact with profilin-actin. VASP, EVL, WASP, gelsolin and mDia1 were able to be phosphorylated in the presence of excess profilin (Fig. 5a) . Indeed, mDia1 appears to show enhanced phosphorylation in the presence of profilin. Thus, the phosphorylation of substrates by YopO is dependent on their recruitment by actin, and/or profilin-actin, in order to present them to the kinase domain (Fig. 5b) . Profilin (Fig. 4a) , Twf1, which consists of two ADF-H domains ( Supplementary Fig. 5) , and CapG, which consists of three gelsolin domains ( Fig. 4g and Supplementary Fig. 5 ), are not sufficiently elongated to span from the actin-binding site to the kinase catalytic cleft in order to be phosphorylated by YopO-actin.
Phosphorylated VASP is attenuated in actin polymerization
Finally we examined the effect of YopO phosphorylation on VASPmediated actin polymerization. We used YopO's preference between actin isoforms to differentiate between actin sequestration and phosphorylation by YopO. The use of rabbit skeletal α-actin minimized the effect of polymerization-incompetent YopO-actin, because skeletal actin is sequestered only weakly by YopO (Fig. 3c) . We preincubated YopO with Sf9-cell cytoplasmic actin and VASP in the (Fig. 5c) . Thus, phosphorylation allows YopO to directly target and diminish the activity of this actin-filament elongator in this in vitro assay.
DISCUSSION
Here we have presented the X-ray structure of Y. enterocolitica YopO in complex with its activator, actin ( Fig. 1 and Table 1 ). The structure reveals that the kinase and GDI domains of YopO sandwich actin subdomain 4, providing the structural basis for actin sequestration and the activation of kinase activity of YopO ( Figs. 1 and 2) . The structure also indicates the basis of the differences in efficiencies of activation of YopO by muscle and cytoplasmic actin isoforms (Fig. 3) 15 . The binding of YopO to actin sterically inhibits polymerization of the bound actin yet allows the bound actin to interact with various proteins that regulate actin polymerization, including filament elongators, formins, nucleationpromoting factors, severing proteins and depolymerizing proteins. This suggests that through binding actin these actin-regulating proteins are sequestered by YopO ( Table 2 and Fig. 4 ). In addition, we have determined that a subset of these proteins, including VASP, EVL, WASP, gelsolin and formin mDia1, are recruited and phosphorylated by YopO in a manner that requires the use of the bound actin as bait (Fig. 5) , which in the case of VASP leads to reduced activity in vitro. Although the contribution of YopO to virulence has been debated 18, 20, 36 , these data provide mechanistic insights into the inhibition of phagocytosis by YopO via modulation of actin polymerization. We propose that YopO has the ability to disrupt phagocytosis via (i) inhibiting signal transduction through sequestration of Rac and Rho 21 ; (ii) inhibiting polymerization at the site of host-pathogen contact through sequestration of actin; and (iii) phosphorylating actin regulators to misregulate polymerization (Fig. 6) . Many pathogens have developed ways to manipulate the actinpolymerization machinery to aid their life cycles. The apicomplexan parasite Toxoplasma secretes toxofilin, which regulates host actin filament-assembly dynamics 37 , whereas a number of pathogenic bacteria npg a r t i c l e s have developed toxins, i.e., actin ADP-ribosylating toxins and actin cross-linking toxins 38 , that directly target actin (comparison of their binding interfaces on actin in Supplementary Fig. 6a,b) . YopO takes advantage of the sequence conservation of eukaryotic actin to potentially jump between host species. The stage of disease progression, the transmission and the species within which the actions of YopO are most important have yet to be resolved. The bubonic plague is passed from rats to humans via fleas; this resulted in Y. pestis claiming the lives of an estimated 30-60% of the European human population during the 14th century. Because rat and human cytoplasmic actins share 100% identity, the activities of YopO may be relevant across a range of mammalian species. Many actin-cytoskeletal components have been reported to be regulated by phosphorylation, including WASP and WIP 39 , VASP and EVL 40 , CapG and gelsolin 41 and mDia1 (ref. 42) . This work has shown that YopO phosphorylates WASP, VASP, gelsolin and mDia1, whereas WIP and INF2 have yet to be assayed. This gives rise to the hypothesis that YopO hijacks native phosphorylation pathways that occur under nonpathogenic conditions to exert control over actin-cytoskeletal dynamics. Hence, YopO is likely to prove to be a valuable tool for the study of phosphoregulatory mechanisms of native actin-filament assembly and disassembly machineries.
The location of self-phosphorylation sites outside of the core kinase domain, combined with the paucity of interactions between the kinase and GDI domains in the actin-bound structure, suggests that YopO may acquire an alternative autoinhibited conformation in the absence of actin (Supplementary Fig. 6c ). We hypothesize that before binding actin, residues 89-107, containing autophosphorylated residues Ser90 and Ser95, fold back onto the catalytic cleft as an autoinhibitory sequence. Given the conformation differences between the reported GDI domain 20 and the GDI domain in the YopO-actin complex, we speculate that binding of actin would induce a multistage activation process, which includes bending of the backbone helix of the GDI domain and further conformational changes that lead to sandwiching of actin between the two domains. The reorganization of domains induced by actin binding would result in the orientation of the catalytic elements within the kinase domain into the active state, and this in turn would lead to autophosphorylation of residues Ser90 and Ser95 and release of the autoinhibition sequence, thus giving rise to the kinase substrate-binding groove being exposed.
The structure of the YopO-actin complex is concordant with previously reported mutation and deletion studies that were used to map out the relative contributions of the GDI and the kinase domains. Constructs comprising solely the GDI domain give rise to an intermediate phenotype of cytoskeletal disruption compared to that of YopO WT 20 , whereas constructs with just the kinase domain no longer cause cytoskeletal disruption 43 . These data led to the conclusion that the GDI domain is the dominant contributor to actin-cytoskeletal disruption 20, 43 . The YopO-actin structure reveals that this conclusion is only part of the mechanism, because actin sequestration and phosphorylation require a functional actin-binding interface including both the GDI and kinase domains. This structure also clarifies the low level of cytoskeletal disruption that was previously observed with dual mutations to the catalytic residues of the kinase domain and the Rac-binding interface of YopO 20 . This can be attributed to the sequestration of actin by YopO, an activity independent of kinase and GDI functions. This work also supports the observations that overexpression of the YopO kinase-dead mutant gives rise to a reduction, and not total abrogation, of filament disruption 19, 20 ; this difference is due to the phosphorylation of actin-binding proteins by YopO, which modulates the activities of effector proteins, particularly those not downstream of Rac and RhoA signaling, such as VASP, EVL and gelsolin.
When taken together, these data suggest the series of events that lead to YopO inhibition of phagocytosis. YopO is produced in the bacteria as an inactive agent 17 . Upon injection into the mammalian cell through the T3SS, YopO senses the environment of the host cytoplasm through binding to actin, hence leading to kinase activation, and localizes via the membrane-association domain to the inner surface of the plasma membrane proximal to the bacterium site of attachment 16, 43 (model in Fig. 6 ). YopO is further restricted in its localization to areas of actin polymerization through binding to Rac and RhoA 21 while inhibiting Rac-and Rho-mediated actin assembly in the phagocytic cup 43 . YopO's sequestration of G-actin prevents its integration into a filament, yet the YopO-actin complex binds freely to VASP, EVL, formins, WASP and WIP. We hypothesize that binding of these proteins to YopO-sequestered polymerizationincompetent G-actin blocks their activities at the membrane, halting the actin polymerization-driven membrane deformation necessary for phagocytosis. Because the YopO-actin complex is localized at the membrane at the Yersinia contact site, through the membranetargeting domain and interactions with Rho and Rac, a relatively low amount of injected YopO would be effective relative to a freely diffusible effector. In addition, the actin-activated YopO kinase domain phosphorylates these actin polymerization-regulatory proteins, to result in misregulation of cellular actin dynamics upon release from YopO. Thus, YopO counteracts host defenses by launching a threepronged attack on disrupting actin dynamics within the macrophage: inhibiting signaling, blocking polymerization at the site of hostpathogen contact and misregulating the actin-remodeling machineries via phosphorylation. These combined actions may be expected to contribute to the inhibition of phagocytosis to prevent the clearance of Yersinia in the host.
METHODS
Methods and any associated references are available in the online version of the paper. 
a r t i c l e s
In vitro phosphorylation. YopO or YopO mutants (4.7 µM), were mixed with G-actin (4.7 µM) in the presence or absence of substrates (4.7 µM) and/or G1 (14.1 µM) or profilin (14.1 µM), and adjusted to 10 µl in 2 mM HEPES, pH 7.6, 0.2 mM ATP, 0.5 mM DTT, 0.1 mM CaCl 2 , and 1 mM Na azide. In the substratephosphorylation assays, all substrates tested were full-length proteins without fusion tags except for mDia1 (residues 583-1262) and WASP (150-502), which contained both an N-terminal GST and a C-terminal His 6 tag. The reaction was initiated by addition of an equal volume of kinase buffer containing 40 mM HEPES, pH 7.6, 2.0 mM ATP, 2 mM DTT, 20 mM MgCl 2 , and 4 mM MnCl 2 , supplemented with 5 µCi of [γ-32 P]ATP. The phosphorylation reactions were allowed to take place for 30 min at 30 °C and were terminated by the addition of SDS-PAGE sample buffer and heating for 5 min at 95 °C. For WASP in particular, because it migrated at a similar position on SDS-PAGE as YopO, thrombin protease was added postphosphorylation to remove the GST tag. Proteins were separated by SDS-PAGE and visualized by Coomassie staining, and radioactivity in the dried SDS-PAGE gels was visualized by exposure to X-ray film.
Phosphorylation of VASP for actin polymerization assay. VASP (2.5 µM) was preincubated with YopO or YopO KD (1.25 µM) in the presence of Sf9 actin (1.25 µM) at 30 min at 30 °C in 20 mM HEPES, pH 7.6, 1.0 mM ATP, 1 mM DTT, 10 mM MgCl 2 , and 2 mM MnCl 2 to allow phosphorylation to take place. In parallel, for the -ATP control, VASP was mixed with YopO and Sf9 actin in the absence of ATP, MgCl 2 and MnCl 2 , and was left on ice. The YopO-phosphorylated VASP or the controls were added to the pyrene-actin polymerization reaction containing rabbit muscle α-actin (2 µM, 10% pyrene labeled) and 2.8 µM profilin. VASP and YopO (or YopO KD) were present in the actin polymerization reaction at final concentrations of 0.25 µM and 0.125 µM, respectively.
